Gene__Phenotype,centrality
BRAF,42405.85662876132
CTNNB1,28036.89469380332
NF1,18657.24427096445
RB1,12678.737881176638
MEN1,11526.395395167743
PDGFRB,9074.374118004609
CDH1,8575.68240913276
GRIN2A,8337.905692797103
PPARG,8103.218185236294
TSC1,7293.13400611379
PRKAR1A,7119.768387555616
FASN,5291.2659055385375
PPP2R1A,4435.529512404623
FZR1,4349.045339122074
"DIABETES MELLITUS, NONINSULIN-DEPENDENT",4071.0
ESR1,3767.2834522113835
Autosomal Recessive Mental Retardation,3575.0
MYB,3359.130696608704
GCK,3075.0
NFE2L2,2638.190410092911
PMS2,2553.527168007368
STAT6,2288.0889323305764
RAC1,2002.361067733708
bladder carcinoma,1935.8018442980356
colorectal adenocarcinoma,1935.8018442980353
colon adenocarcinoma,1935.8018442980353
Lung adenocarcinoma,1935.8018442980353
Cutaneous melanoma,1935.8018442980353
Melanoma,1907.9566868835193
Breast carcinoma,1885.1539643524764
Endometrial Endometrioid Adenocarcinoma,1885.1539643524764
breast ductal adenocarcinoma,1885.1539643524764
cecum adenocarcinoma,1863.8923328763412
gastric adenocarcinoma,1857.5082846684109
Esophageal Squamous Cell Carcinoma,1849.5667065115326
Clear cell renal carcinoma,1820.969405806321
Hepatocellular Carcinoma,1678.901114017068
prostate adenocarcinoma,1666.2294848355841
squamous cell lung carcinoma,1621.2698960021746
thyroid carcinoma,1617.9161036099194
bile duct carcinoma,1606.8196249138202
Small cell lung carcinoma,1584.0457772861382
Basal cell carcinoma,1556.9352430793883
LAMA1,1542.0
bladder transitional cell carcinoma,1509.7414503335856
rectal adenocarcinoma,1479.7776942555229
pancreatic ductal adenocarcinoma,1420.200750833134
prostate carcinoma,1399.1783027356882
cervical squamous cell carcinoma,1384.1597286513718
NCOR2,1360.048965839659
Esophageal adenocarcinoma,1289.1843060015278
gastric intestinal type adenocarcinoma,1284.2789673647717
DNAJB1,1221.9033631137443
CTNND1,1212.9544566220743
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma,1189.0261623412412
Lung carcinoma,1179.931335785487
FGFR4,1130.0138422402852
Merkel cell skin cancer,1127.5114843036297
Papillary thyroid carcinoma,1085.1865996776364
CDK6,1079.8513009204937
ovarian serous adenocarcinoma,1043.9214849027153
ASCL1,1029.0
HER2 Positive Breast Carcinoma,860.1596806150142
head and neck squamous cell carcinoma,842.8489886574351
oral cavity cancer,828.400824577383
pancreatic neuroendocrine tumor,814.9568227876036
invasive lobular carcinoma,803.2504793857225
Pancreatic Acinar Cell Carcinoma,797.2894675208337
nasopharyngeal squamous cell carcinoma,796.2767056926872
follicular thyroid carcinoma,794.881812327683
oral squamous cell carcinoma,793.1406783467539
diffuse large B-cell lymphoma,768.4497431371786
esophageal carcinoma,753.3218280383603
Gallbladder Adenocarcinoma,753.2806293504402
central nervous system cancer,743.2108073217421
diffuse gastric adenocarcinoma,710.7033598932658
non-small cell lung carcinoma,696.3182475084865
Ampulla of Vater Carcinoma,677.4127524030181
FOXO3,671.7028233761004
Pleural Epithelioid Mesothelioma,671.3830990179724
Papillary renal cell carcinoma,620.7574541903099
Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,557.5897227526043
lymphoid neoplasm,549.7495972430402
Chronic lymphocytic leukemia,530.0792306570528
Acute myeloid leukemia,510.66190149534475
leiomyosarcoma,496.0957794908336
Mixed Lobular and Ductal Breast Carcinoma,496.0857037785558
thyroid neoplasm,486.7342978323642
pharyngeal squamous cell carcinoma,483.9394823420699
Breast Carcinoma by Gene Expression Profile,465.68060038578943
HIF1A,457.04706899442675
undifferentiated pleomorphic sarcoma,429.83454284154595
HSP90AA1,424.3776538262235
ovarian carcinoma,421.4399066875028
Uterine Carcinosarcoma,402.98208173889907
Pleural Biphasic Mesothelioma,394.8461321575133
T-cell acute lymphoblastic leukemia,381.27368842325706
NCOA4,376.98239943728566
NFATC2,359.8351330345138
adrenal cortex carcinoma,354.16702406426083
pancreatic carcinoma,354.16702406426083
gastric carcinoma,353.2694105744644
metaplastic breast carcinoma,347.8834913308448
embryonal rhabdomyosarcoma,333.6239495694353
Endometrial Clear Cell Adenocarcinoma,320.6309003864113
Appendix Adenocarcinoma,317.31402146963325
colon carcinoma,305.1451895693648
Ovarian Endometrioid Adenocarcinoma,297.5182531160733
OSTEOSARCOMA,293.60524213819065
Duodenal Adenocarcinoma,285.58162346229227
adenosquamous lung carcinoma,278.1306047965527
Endometrial carcinoma,265.7723902591377
ovarian mucinous adenocarcinoma,240.5704701784865
Bladder Adenocarcinoma,219.88918324577335
endometrium adenocarcinoma,213.69910329371947
Invasive Breast Carcinoma,188.29330167643812
adrenocortical adenoma,181.31239631588628
neoplasm of mature B-cells,169.3558736689644
Ocular Sebaceous Carcinoma,169.22054539531814
MYELODYSPLASTIC SYNDROME,168.34877070848788
bronchoalveolar adenocarcinoma,161.0588656620576
Cortisol-Producing Adrenal Cortex Adenoma,160.3338378611326
angiosarcoma,158.921073941109
angioimmunoblastic T-cell lymphoma,151.92156844412133
Conjunctival Melanoma,151.80518944060665
Multiple myeloma,147.4294195864031
ND,144.07003268812332
Dysplasia in Ulcerative Colitis,139.89154353219104
pulmonary blastoma,139.85113220222854
ovarian teratoma,139.6895944571758
Acute lymphoblastic leukemia,136.07974443789178
Ulcerative colitis,132.5415829193079
Rhabdomyosarcoma,130.8569895107409
kidney neoplasm,130.4396961896156
Gliosarcoma,127.93514675735153
Ovarian neoplasm,125.67688854372516
Laryngeal squamous cell carcinoma,124.93566479949038
Renal cell carcinoma,124.16173738417903
B-cell acute lymphoblastic leukemia,123.23603234905396
lung carcinoid tumor,113.29538732183683
Thyroid Gland Oncocytic Follicular Carcinoma,107.26576262772582
Anal Squamous Cell Carcinoma,106.80339816351984
Chronic myelomonocytic leukemia,106.73476600128075
testicular seminoma,105.88558044002788
VCP,105.0
Colorectal adenoma,95.8349990958576
liposarcoma,95.8349990958576
Benign Thyroid Gland Neoplasm,92.55046339413366
CASP9,90.64883983172314
soft tissue sarcoma,87.58690162631694
ovarian clear cell adenocarcinoma,86.16523218071436
adrenal gland pheochromocytoma,84.6302022074149
Alveolar rhabdomyosarcoma,84.12002460079118
Oligoastrocytoma,80.73329360512072
Hairy cell leukemia,75.30434867216356
Gastric Neuroendocrine Tumor G1,72.96449498356797
Endometrial Undifferentiated Carcinoma,66.32831040116395
Non-Functional Pancreatic Neuroendocrine Tumor,65.62921287208738
MYH6,65.0
Thymic Undifferentiated Carcinoma,63.61884391868104
Salivary Gland Carcinoma ex Pleomorphic Adenoma,62.270142844880425
Neoplasm,62.270142844880425
Amyotrophic lateral sclerosis,62.0
pseudomyxoma peritonei,59.78367896799904
large cell lung carcinoma,59.08922509191361
Astrocytoma,56.988802630890156
Thymic Squamous Cell Carcinoma,56.988802630890156
Chromophobe renal cell carcinoma,55.14179279974004
blue nevus,49.564092712845145
transitional cell carcinoma of kidney,47.55420705216837
Adamantinomatous Craniopharyngioma,47.55420705216837
Craniopharyngioma,47.55420705216837
Rectal Traditional Serrated Adenoma,47.55420705216837
Borderline Ovarian Serous Tumor,47.55420705216837
cervical adenocarcinoma,47.55420705216837
Synovial sarcoma,47.55420705216837
Atypical Endometrial Hyperplasia,47.55420705216837
Gallbladder Adenoma,47.55420705216837
IGF2,45.0
Follicular Variant Thyroid Gland Papillary Carcinoma,44.97796675201776
Differentiated thyroid carcinoma,44.97796675201776
Vulvar Squamous Cell Carcinoma,43.37740708276927
Malignant peripheral nerve sheath tumor,43.27509952892263
Prostate Small Cell Carcinoma,40.10399100472
Lung Sarcomatoid Carcinoma,36.79314778902702
ovarian adenocarcinoma,36.14661369991709
GLB1,36.0
Hashimoto's thyroiditis,35.46151541359773
Parotid Gland Adenoid Cystic Carcinoma,33.39599317719081
Adrenal Gland Neuroblastoma,30.80492695732436
Appendix Goblet Cell Carcinoid,29.594013397691157
Juvenile Xanthogranuloma,29.594013397691157
MATR3,29.0
Angiofibroma,28.9016426307007
marginal zone B-cell lymphoma,28.05981723017452
Thyroid Gland Diffuse Large B-Cell Lymphoma,28.05981723017452
INSR,28.0
Anaplastic oligodendroglioma,25.936332602128907
Anaplastic astrocytoma,25.936332602128907
Bladder Small Cell Neuroendocrine Carcinoma,22.850131010643697
Cervical Small Cell Carcinoma,22.575750540273162
Pleural Mesothelioma,22.344459441560147
desmoplastic medulloblastoma,22.344459441560147
Malignant Ovarian Mixed Epithelial Tumor,22.344459441560147
Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,22.2896386796255
Ovarian Carcinosarcoma,21.473183621126463
PAH,21.0
Medulloblastoma,20.527969497864735
Signet Ring Cell Gastric Adenocarcinoma,20.527969497864735
Medullomyoblastoma with Myogenic Differentiation,20.527969497864735
Dedifferentiated liposarcoma,20.527969497864735
unspecified peripheral T-cell lymphoma,20.07022933113611
colonic neoplasm,19.98380576156287
Testicular Embryonal Carcinoma,18.077447081311405
Sinonasal Undifferentiated Carcinoma,16.50390757365346
Ileal Neuroendocrine Tumor G1,16.396042435779545
Adenoid Cystic Breast Carcinoma,15.73572324555624
IFNG,15.0
SPECC1L,15.0
IL6,15.0
FLNC,15.0
PPP3CA,15.0
Adult hepatocellular carcinoma,14.965529304581123
"OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED",13.637305188947693
Ependymoma,13.499269463130618
Undetermined early-onset epileptic encephalopathy,12.0
Extramammary Paget Disease,11.488894380875097
Borderline Ovarian Surface Epithelial-Stromal Tumor,11.488894380875097
Familial isolated dilated cardiomyopathy,11.0
GABRB2,11.0
Kidney Medullary Carcinoma,10.881641567309083
FN1,10.0
HTRA2,10.0
FOXG1,10.0
IL2RA,10.0
POLYCYTHEMIA VERA,8.34730334457504
Malignant Urinary System Neoplasm,8.20233901811733
pleomorphic liposarcoma,8.20233901811733
HEPATOBLASTOMA,7.035363447278302
Placental Choriocarcinoma,6.366769622578864
UBB,6.0
DLX3,6.0
HTT,6.0
TNFRSF1A,6.0
GFI1B,6.0
RASA1,6.0
Parathyroid Gland Carcinoma,4.304315463017604
Central Nervous System Lymphoma,3.7413915709558596
Tonsillar Squamous Cell Carcinoma,3.710094452822954
Bladder Squamous Cell Carcinoma,3.710094452822954
Breast Cancer,3.214401785101942
INVS,3.0
PIK3CD,3.0
LIPA,3.0
LPAR6,3.0
GFAP,3.0
malignant epithelioid mesothelioma,2.791826585294422
Blepharo-cheiro-dontic syndrome,1.3081413311983991
Blepharo-cheilo-odontic syndrome,1.3081413311983991
IGF1R,1.0
ITGA2,1.0
LSS,1.0
PIKFYVE,1.0
MAPK10,1.0
CD81,1.0
TECR,1.0
VCAN,1.0
ARL6IP1,1.0
MVD,1.0
AKR1C2,1.0
VPS33A,1.0
ABCB1,1.0
Kidney Oncocytoma,0.808848890830815
Malignant Germ Cell Tumor,0.6183195154825646
pancreatic neoplasm,0.3858510412136055
Spinal Cord Astrocytoma,0.32013900786015614
Hidradenocarcinoma,0.10546337201484546
Peritoneal Mesothelioma,0.10546337201484546
Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ,0.10546337201484546
Atypical Lobular Breast Hyperplasia,0.10546337201484546
ductal carcinoma in situ,0.10546337201484546
Lobular Breast Carcinoma In Situ,0.10546337201484546
pulmonary mucoepidermoid carcinoma,0.10546337201484546
Tracheal Squamous Cell Carcinoma,0.10546337201484546
Senior-Loken syndrome,0.0
NEPHRONOPHTHISIS 2,0.0
Infantile nephronophthisis,0.0
smooth muscle tumor,0.0
Parathyroid Hyperplasia,0.0
Pancreatic Vipoma,0.0
Lipoma,0.0
CHONDROSARCOMA,0.0
Multiple endocrine neoplasia type 1,0.0
Pancreatic Gastrinoma,0.0
Silent pituitary adenoma,0.0
"MULTIPLE ENDOCRINE NEOPLASIA, TYPE I",0.0
Mixed Somatotroph-Lactotroph Pituitary Gland Adenoma,0.0
Null pituitary adenoma,0.0
Duodenal Gastrin-Producing Neuroendocrine Tumor,0.0
ACTH-Producing Pituitary Gland Adenoma,0.0
pancreatic somatostatinoma,0.0
Insulinoma,0.0
Familial isolated hyperparathyroidism,0.0
Pancreatic Glucagonoma,0.0
Prolactinoma,0.0
Prolactin-Producing Pituitary Gland Adenoma,0.0
carcinoid tumor,0.0
Non-phenylketonuria hyperphenylalaninemia,0.0
Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria,0.0
Mild phenylketonuria,0.0
Classic phenylketonuria,0.0
Maternal phenylketonuria,0.0
Mild hyperphenylalaninemia,0.0
PHENYLKETONURIA,0.0
Lynch syndrome,0.0
MISMATCH REPAIR CANCER SYNDROME,0.0
"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4",0.0
Constitutional mismatch repair deficiency syndrome,0.0
"IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA",0.0
Carcinoma,0.0
IMMUNODEFICIENCY 14,0.0
Combined immunodeficiency with faciooculoskeletal anomalies,0.0
Activated PI3K-delta syndrome,0.0
Prostate Cancer,0.0
Endometrial Cancer,0.0
Hereditary diffuse gastric cancer,0.0
"GASTRIC CANCER, HEREDITARY DIFFUSE",0.0
Cleft lip/palate,0.0
BLEPHAROCHEILODONTIC SYNDROME 1,0.0
Acute basophilic leukemia,0.0
Submandibular Gland Adenoid Cystic Carcinoma,0.0
Angiocentric glioma,0.0
Lacrimal Gland Adenoid Cystic Carcinoma,0.0
Precursor T-cell acute lymphoblastic leukemia,0.0
Lysosomal acid lipase deficiency,0.0
Cholesteryl ester storage disease,0.0
WOLMAN DISEASE,0.0
"INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO",0.0
Growth delay due to insulin-like growth factor I resistance,0.0
SOD2,0.0
"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6",0.0
Testicular Teratoma,0.0
Neurofibromatosis-Noonan syndrome,0.0
Malignant Adrenal Gland Pheochromocytoma,0.0
NEUROFIBROMATOSIS TYPE 1,0.0
Teratoma with Malignant Transformation,0.0
WATSON SYNDROME,0.0
Malignant Paraganglioma,0.0
Unclassified Renal Cell Carcinoma,0.0
Familial spinal neurofibromatosis,0.0
Brain Stem Glioblastoma,0.0
17q11 microdeletion syndrome,0.0
Plexiform neurofibroma,0.0
Benign Adrenal Gland Pheochromocytoma,0.0
Juvenile myelomonocytic leukemia,0.0
neurofibroma,0.0
"NEUROFIBROMATOSIS, FAMILIAL SPINAL",0.0
ganglioneuroma,0.0
Myelodysplastic/Myeloproliferative Neoplasm,0.0
Neurofibromatosis type 1 due to NF1mutation or intragenic deletion,0.0
17q11.2 microduplication syndrome,0.0
Ovarian Granulosa Cell Tumor,0.0
"NEUROFIBROMATOSIS, TYPE I",0.0
"APLASTIC ANEMIA APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED",0.0
"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO",0.0
"HEPATITIS C VIRUS, SUSCEPTIBILITY TO",0.0
"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED",0.0
Idiopathic aplastic anemia,0.0
Tuberous sclerosis 2,0.0
CD4,0.0
OKT4 EPITOPE DEFICIENCY,0.0
"Spondylometaphyseal dysplasia, 'corner fracture' type",0.0
Spondylometaphyseal Dysplasia with Corner Fractures,0.0
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2,0.0
PLASMA FIBRONECTIN DEFICIENCY,0.0
Fibronectin glomerulopathy,0.0
CCNF,0.0
Submucosal cleft palate,0.0
Bifid uvula,0.0
Cleft hard palate,0.0
Cleft velum,0.0
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism,0.0
TRICHODENTOOSSEOUS SYNDROME,0.0
"AMELOGENESIS IMPERFECTA, TYPE IV",0.0
Tricho-dento-osseous syndrome,0.0
Fetal and neonatal alloimmune thrombocytopenia,0.0
"BLEEDING DISORDER, PLATELET-TYPE, 9",0.0
"FACIAL CLEFTING, OBLIQUE, 1",0.0
"Hypertelorism, Teebi type",0.0
Autosomal dominant Opitz G/BBB syndrome,0.0
Tessier number 7 facial cleft,0.0
"OPITZ GBBB SYNDROME, TYPE II",0.0
Tessier number 4 facial cleft,0.0
AMYOTROPHIC LATERAL SCLEROSIS 21,0.0
Vocal cord and pharyngeal distal myopathy,0.0
Systemic-onset juvenile idiopathic arthritis,0.0
"DIABETES MELLITUS, INSULIN-DEPENDENT",0.0
ARTERIOVENOUS MALFORMATIONS OF THE BRAIN,0.0
INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1,0.0
"KAPOSI SARCOMA, SUSCEPTIBILITY TO",0.0
"RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE",0.0
THBS2,0.0
INTERVERTEBRAL DISC DISEASE,0.0
PPARGC1A,0.0
Benign Ovarian Mucinous Tumor,0.0
Total early-onset cataract,0.0
Cataract 44,0.0
BECKWITH-WIEDEMANN SYNDROME,0.0
"Growth restriction, severe, with distinctive facies",0.0
WILMS TUMOR 1,0.0
SILVER-RUSSELL SYNDROME,0.0
Isolated hemihyperplasia,0.0
Silver-Russell syndrome due to an imprinting defect of 11p15,0.0
Chromosome 11p15.5-Related Russell-Silver Syndrome,0.0
Silver-Russell syndrome due to a point mutation,0.0
Silver-Russell syndrome due to 11p15 microduplication,0.0
Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,0.0
FLECK CORNEAL DYSTROPHY,0.0
"CORNEAL DYSTROPHY, FLECK",0.0
Permanent neonatal diabetes mellitus,0.0
"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2",0.0
MODY,0.0
"DIABETES MELLITUS, PERMANENT NEONATAL",0.0
Hyperinsulinism due to glucokinase deficiency,0.0
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3",0.0
PPARG-related familial partial lipodystrophy,0.0
"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3",0.0
CAROTID INTIMAL MEDIAL THICKNESS 1,0.0
Giant cell glioblastoma,0.0
"OBESITY LEANNESS, INCLUDED",0.0
Berardinelli-Seip congenital lipodystrophy,0.0
PTPN1,0.0
TNK2,0.0
Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,0.0
"MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED",0.0
Usual Ductal Breast Hyperplasia,0.0
Estrogen resistance syndrome,0.0
"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1",0.0
ESTROGEN RESISTANCE,0.0
Woolly hair,0.0
Hypotrichosis simplex,0.0
HYPOTRICHOSIS 8,0.0
Juvenile Huntington disease,0.0
HUNTINGTON DISEASE,0.0
LOPES-MACIEL-RODAN SYNDROME,0.0
Obsessive-compulsive disorder,0.0
"Cardiomyopathy, familial hypertrophic, 26",0.0
Distal myopathy with posterior leg and anterior hand involvement,0.0
"MYOPATHY, DISTAL, 4",0.0
Muscle filaminopathy,0.0
Familial isolated restrictive cardiomyopathy,0.0
"MYOPATHY, MYOFIBRILLAR, 5",0.0
Fibrolamellar Carcinoma,0.0
Fibrolamellar hepatocellular carcinoma,0.0
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4",0.0
Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement,0.0
Myeloproliferative disorder,0.0
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome,0.0
"MYOFIBROMATOSIS, INFANTILE, 1",0.0
Kosaki overgrowth syndrome,0.0
"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1",0.0
Familial Infantile Myofibromatosis,0.0
"PREMATURE AGING SYNDROME, PENTTINEN TYPE",0.0
Infantile myofibromatosis,0.0
Bilateral striopallidodentate calcinosis,0.0
"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",0.0
"Chronic myeloproliferative disease, unclassifiable",0.0
Primary hypereosinophilic syndrome,0.0
Acroosteolysis-keloid-like lesions-premature aging syndrome,0.0
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 36",0.0
Maxillary Sinus Adenoid Cystic Carcinoma,0.0
Intellectual disability,0.0
Cervical Clear Cell Adenocarcinoma,0.0
Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,0.0
Thymoma Type B3,0.0
SHROOM3,0.0
Neural tube defect,0.0
Epileptic encephalopathy Lennox-Gastaut type,0.0
Lennox-Gastaut syndrome,0.0
BLEPHAROCHEILODONTIC SYNDROME 2,0.0
AIMP2,0.0
"LEUKODYSTROPHY, HYPOMYELINATING, 17",0.0
Young-onset Parkinson disease,0.0
3-methylglutaconic aciduria type 8,0.0
"PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",0.0
"3-METHYLGLUTACONIC ACIDURIA, TYPE VIII",0.0
Early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria,0.0
Tuberous sclerosis 1,0.0
Pineal Parenchymal Tumor of Intermediate Differentiation,0.0
Tuberous sclerosis complex,0.0
dedifferentiated chondrosarcoma,0.0
Thymic Carcinoma,0.0
LYMPHANGIOLEIOMYOMATOSIS,0.0
Benign Brain Neoplasm,0.0
TUBEROUS SCLEROSIS TYPE 1,0.0
Isolated focal cortical dysplasia type IIb,0.0
fibroma,0.0
"FOCAL CORTICAL DYSPLASIA, TYPE II",0.0
Solitary fibrous tumor,0.0
Splenic Diffuse Large B-Cell Lymphoma,0.0
Dedifferentiated Solitary Fibrous Tumor,0.0
Cutaneous Follicular Lymphoma,0.0
"Atrial septal defect, ostium secundum type",0.0
Familial sick sinus syndrome,0.0
ATRIAL SEPTAL DEFECT 3,0.0
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14",0.0
"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1",0.0
"SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO",0.0
ATRIAL SEPTAL DEFECT TYPE 3,0.0
CARDIOMYOPATHY DILATED TYPE 1EE,0.0
"CARDIOMYOPATHY, DILATED, 1EE",0.0
CARDIOMYOPATHY FAMILIAL HYPERTROPHIC TYPE 14,0.0
"IMMUNODEFICIENCY, COMMON VARIABLE, 6",0.0
Common variable immunodeficiency,0.0
TBC1D4,0.0
"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5",0.0
"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14",0.0
Autosomal recessive non-syndromic intellectual disability,0.0
ACAT2,0.0
ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY,0.0
Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma,0.0
TCF20,0.0
TCF20 syndrome,0.0
"Rett syndrome, congenital variant",0.0
14q11.2 microduplication syndrome,0.0
CONGENITAL VARIANT OF RETT SYNDROME,0.0
Atypical Rett syndrome,0.0
14q12 microdeletion syndrome,0.0
Cerebellar dysplasia with cysts with or without retinal dystrophy,0.0
Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,0.0
Poretti-boltshauser syndrome,0.0
Wagner disease,0.0
WAGNER VITREORETINOPATHY,0.0
"SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE",0.0
Autosomal recessive spastic paraplegia type 61,0.0
Disseminated superficial actinic porokeratosis,0.0
"Porokeratosis 7, multiple types",0.0
Acrodysostosis,0.0
Testicular Large Cell Calcifying Sertoli Cell Tumor,0.0
schwannoma,0.0
"MYXOMA, INTRACARDIAC",0.0
Carney complex,0.0
"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1",0.0
Acrodysostosis with multiple hormone resistance,0.0
ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,0.0
Familial atrial myxoma,0.0
Primary pigmented nodular adrenocortical disease,0.0
Growth Hormone-Producing Pituitary Gland Adenoma,0.0
"Carney complex, type 1",0.0
ACUTE PROMYELOCYTIC LEUKEMIA,0.0
Epilepsy and intellectual disability,0.0
"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2",0.0
Rheumatoid factor-negative juvenile idiopathic arthritis,0.0
Oligoarticular juvenile idiopathic arthritis,0.0
Immunodeficiency due to CD25 deficiency,0.0
IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY,0.0
"DIABETES MELLITUS, INSULIN-DEPENDENT, 10",0.0
"46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",0.0
"46,XY SEX REVERSAL 8",0.0
IL11,0.0
Craniosynostosis and dental anomalies,0.0
Tumor necrosis factor receptor 1 associated periodic syndrome,0.0
"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5",0.0
Intermittent hydrarthrosis,0.0
"PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT",0.0
GM1-GANGLIOSIDOSIS TYPE 1,0.0
GM1 gangliosidosis type 1,0.0
GM1 gangliosidosis type 3,0.0
Mucopolysaccharidosis type 4B,0.0
"MUCOPOLYSACCHARIDOSIS, TYPE IVB",0.0
GM1 gangliosidosis type 2,0.0
"GM1-GANGLIOSIDOSIS, TYPE II",0.0
"GM1-GANGLIOSIDOSIS, TYPE III",0.0
"GM1-GANGLIOSIDOSIS, TYPE I",0.0
Autosomal recessive primary microcephaly,0.0
"Microcephaly 12, primary, autosomal recessive",0.0
PSMB4,0.0
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3,0.0
TGFBR3,0.0
Familial cerebral saccular aneurysm,0.0
brain neoplasm,0.0
"DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS",0.0
"Insulin resistance syndrome, type A",0.0
DONOHUE SYNDROME,0.0
RABSON-MENDENHALL SYNDROME,0.0
"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5",0.0
Hyperinsulinism due to INSR deficiency,0.0
Leprechaunism,0.0
"PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES",0.0
ANKRD1,0.0
OSTEOGENIC SARCOMA,0.0
Rectal Tubular Adenoma,0.0
Monosomy 13q14,0.0
RETINOBLASTOMA,0.0
Hereditary retinoblastoma,0.0
Small cell lung cancer,0.0
Bladder Cancer,0.0
Non-hereditary retinoblastoma,0.0
Small cell cancer of the lung,0.0
Pancreatic Small Cell Neuroendocrine Carcinoma,0.0
Basaloid Carcinoma,0.0
cervical carcinoma,0.0
Pancreatic Large Cell Neuroendocrine Carcinoma,0.0
Lung Giant Cell Carcinoma,0.0
Kidney Angiomyolipoma,0.0
Fibroadenoma,0.0
Fallopian Tube Serous Adenocarcinoma,0.0
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME,0.0
Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,0.0
Cervical Adenosquamous Carcinoma,0.0
breast adenosis,0.0
Gastric Mantle Cell Lymphoma,0.0
Secretory Meningioma,0.0
Rolandic epilepsy,0.0
Landau-Kleffner syndrome,0.0
"Epilepsy, focal, with speech disorder and with or without mental retardation",0.0
renal carcinoma,0.0
Rolandic epilepsy-speech dyspraxia syndrome,0.0
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation,0.0
Epilepsy with neurodevelopmental defects,0.0
Continuous spikes and waves during sleep,0.0
Alexander disease,0.0
Alexander disease type II,0.0
Alexander disease type I,0.0
Haddad syndrome,0.0
"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL",0.0
Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,0.0
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 48",0.0
Developmental Disorders with Diverse Phenotypes,0.0
Severe intellectual disability-progressive spastic diplegia syndrome,0.0
Ovarian Mixed Epithelial Tumor,0.0
Salivary Gland Pleomorphic Adenoma,0.0
"MENTAL RETARDATION, AUTOSOMAL DOMINANT 19",0.0
Testicular Granulosa Cell Tumor,0.0
Calcifying Nested Epithelial Stromal Tumor of the Liver,0.0
Pancreatoblastoma,0.0
Testicular Sclerosing Sertoli Cell Tumor,0.0
Pilomatrixoma,0.0
hyperplasia,0.0
Solid Pseudopapillary Neoplasm of the Pancreas,0.0
desmoplastic fibroma,0.0
Non-Functioning Adrenal Cortex Adenoma,0.0
spindle cell tumor,0.0
Testicular Sertoli Cell Tumor,0.0
Complex Endometrial Hyperplasia,0.0
Appendix Neuroendocrine Tumor G1,0.0
Ovarian Endometriosis,0.0
Gastric Adenoma,0.0
Major Salivary Gland Carcinoma,0.0
Pediatric hepatocellular carcinoma,0.0
Adenosquamous Carcinoma,0.0
Endometrial Stromal Nodule,0.0
Salivary Gland Basal Cell Adenocarcinoma,0.0
monophasic synovial sarcoma,0.0
Sarcoma,0.0
Familial exudative vitreoretinopathy,0.0
Desmoid tumor,0.0
EXUDATIVE VITREORETINOPATHY 7,0.0
Gastric Hamartomatous Polyp,0.0
Colorectal Neuroendocrine Tumor G1,0.0
Borderline Ovarian Endometrioid Tumor,0.0
Primary Intraosseous Squamous Cell Carcinoma,0.0
Ovarian Microcystic Stromal Tumor,0.0
hepatocellular adenoma,0.0
Colorectal Hamartoma,0.0
skin appendage carcinoma,0.0
Endometrial Squamous Cell Carcinoma,0.0
Fibrosarcoma,0.0
Colorectal Cancer,0.0
Benign Ovarian Brenner Tumor,0.0
INFLAMMATORY BOWEL DISEASE 13,0.0
COLCHICINE RESISTANCE,0.0
Adult-onset distal myopathy due to VCP mutation,0.0
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,0.0
Spastic paraplegia-Paget disease of bone syndrome,0.0
AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,0.0
Frontotemporal dementia with motor neuron disease,0.0
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1,0.0
Behavioral variant of frontotemporal dementia,0.0
Progressive non-fluent aphasia,0.0
Autosomal dominant Charcot-Marie-Tooth disease type 2Y,0.0
"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y",0.0
GRAY PLATELET SYNDROME,0.0
Autosomal dominant macrothrombocytopenia,0.0
Alpha delta granule deficiency,0.0
"BLEEDING DISORDER, PLATELET-TYPE, 17",0.0
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION,0.0
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1,0.0
PARKES WEBER SYNDROME,0.0
"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1",0.0
malignant rhabdoid tumour,0.0
Rectal Hyperplastic Polyp,0.0
LEOPARD SYNDROME TYPE 3,0.0
Histiocytic and Dendritic Cell Neoplasm,0.0
Ameloblastic Carcinoma,0.0
LEOPARD SYNDROME 3,0.0
Borderline Ovarian Mucinous Tumor,0.0
testicular neoplasm,0.0
Endometrial Mucinous Adenocarcinoma,0.0
Testicular Yolk Sac Tumor,0.0
Hyperplastic Polyp,0.0
Colorectal Serrated Adenocarcinoma,0.0
Metanephric Adenoma,0.0
Classic hairy cell leukemia,0.0
chronic pancreatitis,0.0
Anal Melanoma,0.0
NOONAN SYNDROME 7,0.0
CARDIOFACIOCUTANEOUS SYNDROME,0.0
Conjunctival Nevus,0.0
"LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED",0.0
Breast Diffuse Large B-Cell Lymphoma,0.0
breast tumor luminal,0.0
amelanotic skin melanoma,0.0
Bile Duct Adenoma,0.0
Langerhans Cell Histiocytosis,0.0
Pilomyxoid astrocytoma,0.0
Small Intestinal Diffuse Large B-Cell Lymphoma,0.0
Hashimoto-Pritzker syndrome,0.0
Syringocystadenoma Papilliferum,0.0
Cecum Villous Adenoma,0.0
Desmoplastic Ameloblastoma,0.0
Kaposi's sarcoma,0.0
Jejunal Neuroendocrine Tumor G1,0.0
dysembryoplastic neuroepithelial tumor,0.0
Primary Pulmonary Diffuse Large B-Cell Lymphoma,0.0
NOONAN SYNDROME 1,0.0
Oligodendroglioma,0.0
brain glioblastoma,0.0
Tenosynovial Giant Cell Tumor,0.0
Papillary Craniopharyngioma,0.0
NOONAN SYNDROME TYPE 7,0.0
intradermal nevus,0.0
B-cell non-Hodgkins lymphoma,0.0
Digestive System Carcinoma,0.0
Uveal melanoma,0.0
Lung Signet Ring Cell Carcinoma,0.0
Thyroid Gland Squamous Cell Carcinoma,0.0
Rectal Villous Adenoma,0.0
Adenocarcinoma,0.0
dysplastic nevus,0.0
ganglioglioma,0.0
CARDIOFACIOCUTANEOUS SYNDROME 1,0.0
Salivary Gland Large Cell Carcinoma,0.0
Anaplastic oligoastrocytoma,0.0
B-Cell Prolymphocytic Leukemia,0.0
Nasal Cavity Polyp,0.0
Rhabdoid Meningioma,0.0
T-cell prolymphocytic leukemia,0.0
Micropapillary Serous Carcinoma,0.0
Epithelioid Cell Uveal Melanoma,0.0
Spindle Cell Melanoma,0.0
Mixed Cell Uveal Melanoma,0.0
Colorectal Sessile Serrated Adenoma/Polyp,0.0
Noonan Syndrome,0.0
Noonan syndrome with multiple lentigines,0.0
EMG1,0.0
BOWEN-CONRADI SYNDROME,0.0
Severe Neurodevelopmental Disease with Seizures,0.0
"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1",0.0
Autosomal dominant non-syndromic intellectual disability,0.0